DEFB126
gene geneOn this page
Also known as bA530N10.1DEFB-26
Summary
DEFB126 (defensin beta 126, HGNC:15900) is a protein-coding gene on chromosome 20p13, encoding Beta-defensin 126 (Q9BYW3). Highly glycosylated atypical beta-defensin involved in several aspects of sperm function.
Defensins are cysteine-rich cationic polypeptides that are important in the immunologic response to invading microorganisms. The antimicrobial protein encoded by this gene is secreted and is a member of the beta defensin protein family. Beta defensin genes are found in several clusters throughout the genome, with this gene mapping to a cluster at 20p13. The encoded protein is highly similar to an epididymal-specific secretory protein (ESP13.2) from cynomolgus monkey. Mutation of this gene is associated with impaired sperm function.
Source: NCBI Gene 81623 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 15 total
- MANE Select transcript:
NM_030931
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15900 |
| Approved symbol | DEFB126 |
| Name | defensin beta 126 |
| Location | 20p13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | bA530N10.1, DEFB-26 |
| Ensembl gene | ENSG00000125788 |
| Ensembl biotype | protein_coding |
| OMIM | 620131 |
| Entrez | 81623 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000382398, ENST00000542572
RefSeq mRNA: 2 — MANE Select: NM_030931
NM_001412225, NM_030931
CCDS: CCDS12990
Canonical transcript exons
ENST00000382398 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000858522 | 145415 | 145751 |
| ENSE00001491976 | 142590 | 142686 |
Expression profiles
Bgee: expression breadth broad, 49 present calls, max score 99.32.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 1.1542 / max 1928.3823, expressed in 8 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 182985 | 1.1128 | 7 |
| 182984 | 0.0232 | 2 |
| 182983 | 0.0114 | 2 |
| 208957 | 0.0068 | 2 |
Top tissues by expression
250 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cauda epididymis | UBERON:0004360 | 99.32 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 95.47 | gold quality |
| corpus epididymis | UBERON:0004359 | 95.11 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 89.33 | gold quality |
| sperm | CL:0000019 | 75.61 | silver quality |
| male germ cell | CL:0000015 | 75.11 | silver quality |
| caput epididymis | UBERON:0004358 | 63.27 | gold quality |
| seminal vesicle | UBERON:0000998 | 56.62 | silver quality |
| decidua | UBERON:0002450 | 56.55 | gold quality |
| hair follicle | UBERON:0002073 | 52.43 | gold quality |
| lower lobe of lung | UBERON:0008949 | 52.34 | silver quality |
| ileal mucosa | UBERON:0000331 | 51.41 | silver quality |
| pancreatic ductal cell | CL:0002079 | 51.38 | silver quality |
| deltoid | UBERON:0001476 | 50.72 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 49.70 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 49.30 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 49.20 | gold quality |
| quadriceps femoris | UBERON:0001377 | 49.05 | gold quality |
| olfactory bulb | UBERON:0002264 | 48.92 | gold quality |
| myocardium | UBERON:0002349 | 48.87 | gold quality |
| type B pancreatic cell | CL:0000169 | 48.83 | gold quality |
| oviduct epithelium | UBERON:0004804 | 48.62 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 48.55 | gold quality |
| CA1 field of hippocampus | UBERON:0003881 | 48.50 | gold quality |
| tibialis anterior | UBERON:0001385 | 48.38 | silver quality |
| vastus lateralis | UBERON:0001379 | 48.25 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 48.24 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 48.20 | gold quality |
| upper arm skin | UBERON:0004263 | 48.06 | gold quality |
| cervix epithelium | UBERON:0004801 | 48.04 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.79 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 9)
- Analyses restricted to glioblastoma (n = 254) yielded significant associations for the SELP, DEFB126/127, SERPINI1, and LY96 genetic regions. (PMID:19423540)
- DEFB126 genotype and lectin binding were correlated with sperm performance in the penetration assays. (PMID:21775668)
- This review shows how DEFB126 is critical for efficient transport of sperm in the female reproductive tract, preventing their recognition by the female immune system. (PMID:22710670)
- These results demonstrate that the DEFB126 core peptide has critical functions in parallel to its C-terminal tail by showing LPS-binding activity, anti-inflammatory effects and intracellular regulatory function. In addition, DEFB126 displays antimicrobial activity against E. coli, S. aureus, and C. elegans. (PMID:23229569)
- Data indicate a significant contribution of the frame-shift polymorphism of defensin beta 126 (DEFB126) rs11467497 to male infertility. (PMID:25721098)
- It is a immune component extensively expressed in mucosa and epidermis, which are responsible for the first line of host defense. (PMID:30529003)
- The role of DEFB126 variation in male infertility and medically assisted reproduction technique outcome. (PMID:31474436)
- Beta-defensin126 is correlated with sperm motility in fertile and infertile mendagger. (PMID:31504198)
- DEFB126 polymorphisms and association with idiopathic asthenozoospermia in China. (PMID:35381696)
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Beta-defensin 126 — Q9BYW3 (reviewed: Q9BYW3)
Alternative names: Beta-defensin 26, Defensin, beta 126, Epididymal secretory protein 13.2, HBD26
All UniProt accessions (2): Q9BYW3, A0A384MDP8
UniProt curated annotations — full annotation on UniProt →
Function. Highly glycosylated atypical beta-defensin involved in several aspects of sperm function. Facilitates sperm transport in the female reproductive tract and contributes to sperm protection against immunodetection; both functions are probably implicating the negative surface charge provided by its O-linked oligosaccharides in the sperm glycocalyx. Involved in binding of sperm to oviductal epithelial cells to form a sperm reservoir until ovulation. Release from the sperm surface during capacitation and ovaluation by an elevation of oviductal fluid pH is unmasking other surface components and allows sperm to penetrate the cumulus matrix and bind to the zona pellucida of the oocyte. In vitro has antimicrobial activity and may inhibit LPS-mediated inflammation.
Subunit / interactions. Homodimer or homooligomer; disulfide-linked.
Subcellular location. Secreted.
Tissue specificity. High-level and epididymis-specific expression. Expression is down-regulated in infertile men.
Post-translational modifications. O-glycosylated; glycans contain alpha(2,3)-linked sialic acids.
Disease relevance. May be involved in infertility. Homozygosity for frameshift truncating mutations are associated with reduced sperm O-linked glycan content, impaired sperm mobility and a reduced live birth rate. However, for one common mutation the change in sperm sialic acid levels has been challenged.
Similarity. Belongs to the beta-defensin family.
RefSeq proteins (2): NP_001399154, NP_112193* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR050544 | Beta-defensin | Family |
UniProt features (8 total): disulfide bond 4, signal peptide 1, chain 1, region of interest 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BYW3-F1 | 72.71 | 0.08 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (4): 27–58, 34–52, 38–59, 72
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-1461957 | Beta defensins |
| R-HSA-1461973 | Defensins |
MSigDB gene sets: 34 (showing top):
GOBP_SINGLE_FERTILIZATION, REACTOME_INNATE_IMMUNE_SYSTEM, GOBP_ANTIMICROBIAL_HUMORAL_RESPONSE, ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP, GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, GOBP_HUMORAL_IMMUNE_RESPONSE, GOBP_DEFENSE_RESPONSE_TO_GRAM_NEGATIVE_BACTERIUM, GOBP_FERTILIZATION, GOBP_DEFENSE_RESPONSE_TO_BACTERIUM, GOBP_RESPONSE_TO_BACTERIUM, GOBP_ANTIMICROBIAL_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_ANTIMICROBIAL_PEPTIDE, PRC2_SUZ12_UP.V1_DN, PTEN_DN.V2_UP, REACTOME_ANTIMICROBIAL_PEPTIDES, GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP
GO Biological Process (5): single fertilization (GO:0007338), defense response to Gram-negative bacterium (GO:0050829), antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844), defense response (GO:0006952), defense response to bacterium (GO:0042742)
GO Molecular Function (0):
GO Cellular Component (1): extracellular region (GO:0005576)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Defensins | 1 |
| Antimicrobial peptides | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| fertilization | 1 |
| defense response to bacterium | 1 |
| antimicrobial humoral response | 1 |
| response to stress | 1 |
| defense response | 1 |
| response to bacterium | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
430 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DEFB126 | DEFB118 | Q96PH6 | 749 |
| DEFB126 | DEFB127 | Q9H1M4 | 720 |
| DEFB126 | A0A0G2JN59 | A0A0G2JN59 | 697 |
| DEFB126 | DEFB114 | Q30KQ6 | 667 |
| DEFB126 | DEFB129 | Q9H1M3 | 645 |
| DEFB126 | DEFB128 | Q7Z7B8 | 640 |
| DEFB126 | DEFB106A | Q8N104 | 603 |
| DEFB126 | DEFB113 | Q30KQ7 | 580 |
| DEFB126 | CRISP1 | P54107 | 575 |
| DEFB126 | DEFB125 | Q8N687 | 560 |
| DEFB126 | DEFB1 | P60022 | 553 |
| DEFB126 | DEFB116 | Q30KQ4 | 553 |
| DEFB126 | DEFB105A | Q8NG35 | 552 |
| DEFB126 | DEFB121 | Q5J5C9 | 543 |
| DEFB126 | EPPIN | O95925 | 541 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| Prdm16 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| MAPT | SHTN1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (2): DEFB126 (Affinity Capture-MS), DEFB126 (Affinity Capture-MS)
ESM2 similar proteins: A4H220, A4H221, A4H222, A4H223, A4H238, A4H239, A4H240, A4H241, A4H243, A4H244, A4H245, A4H257, A4H258, A4H259, A4H260, O54947, P59647, P97808, Q17R60, Q30KK0, Q30KK1, Q30KK2, Q30KK3, Q30KK9, Q30KL1, Q30KQ4, Q32ZH2, Q3MIW9, Q5FVR0, Q5XI99, Q62170, Q64294, Q6MG22, Q6U7R4, Q7TST5, Q7Z7G0, Q8JZQ0, Q8N687, Q8R183, Q95152
Diamond homologs: A4H243, A4H244, A4H245, Q30KK2, Q32P86, Q8BVC1, Q9BEE3, Q9BYW3, A4H255, A4H225, A4H226, A4H227, A4H228, Q30KK4, Q30KK8, Q30KT5, Q5J602, Q8K3I8, Q8N690, Q8NES8, A4H223, Q95LI0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
15 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 11 |
| Likely benign | 1 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
364 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:145489:G:GG | donor_gain | 0.9600 |
| 20:145410:TTCA:T | acceptor_loss | 0.9200 |
| 20:145411:TCA:T | acceptor_loss | 0.9200 |
| 20:145412:CAGG:C | acceptor_loss | 0.9200 |
| 20:145413:AGG:A | acceptor_loss | 0.9200 |
| 20:142631:G:GT | donor_gain | 0.8700 |
| 20:142681:TCTC:T | donor_gain | 0.8700 |
| 20:145488:T:G | donor_gain | 0.8700 |
| 20:142742:G:GT | donor_gain | 0.8600 |
| 20:145577:A:AG | acceptor_gain | 0.8500 |
| 20:145578:G:GG | acceptor_gain | 0.8500 |
| 20:145485:GCAT:G | donor_gain | 0.8400 |
| 20:145493:A:G | donor_gain | 0.8300 |
| 20:142682:CTCAG:C | donor_loss | 0.8200 |
| 20:142683:TCAG:T | donor_loss | 0.8200 |
| 20:142684:CAGGT:C | donor_loss | 0.8200 |
| 20:142685:AG:A | donor_loss | 0.8200 |
| 20:142686:G:GC | donor_loss | 0.8200 |
| 20:142687:GTA:G | donor_loss | 0.8200 |
| 20:142688:T:A | donor_loss | 0.8200 |
| 20:145464:G:GT | donor_gain | 0.8100 |
| 20:145492:A:AG | donor_gain | 0.7900 |
| 20:142751:GTTTC:G | donor_gain | 0.7800 |
| 20:142752:TTTCT:T | donor_gain | 0.7800 |
| 20:142755:C:CG | donor_gain | 0.7700 |
| 20:142764:C:A | donor_gain | 0.7600 |
| 20:142800:GGC:G | donor_gain | 0.7600 |
| 20:145414:GGTA:G | acceptor_gain | 0.7600 |
| 20:145413:A:AG | acceptor_gain | 0.7500 |
| 20:145414:G:GG | acceptor_gain | 0.7500 |
AlphaMissense
719 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:145456:T:A | C34S | 0.996 |
| 20:145457:G:C | C34S | 0.996 |
| 20:145528:T:A | C58S | 0.996 |
| 20:145529:G:C | C58S | 0.996 |
| 20:145435:T:A | C27S | 0.995 |
| 20:145436:G:C | C27S | 0.995 |
| 20:145451:G:A | G32E | 0.995 |
| 20:145510:T:A | C52S | 0.995 |
| 20:145511:G:C | C52S | 0.995 |
| 20:145531:T:A | C59S | 0.995 |
| 20:145532:G:C | C59S | 0.995 |
| 20:145468:T:A | C38S | 0.994 |
| 20:145469:G:C | C38S | 0.994 |
| 20:145450:G:A | G32R | 0.993 |
| 20:145450:G:C | G32R | 0.993 |
| 20:145528:T:C | C58R | 0.993 |
| 20:145530:C:G | C58W | 0.993 |
| 20:145456:T:C | C34R | 0.990 |
| 20:145529:G:A | C58Y | 0.990 |
| 20:145435:T:C | C27R | 0.989 |
| 20:145457:G:A | C34Y | 0.989 |
| 20:145468:T:C | C38R | 0.989 |
| 20:145437:T:G | C27W | 0.988 |
| 20:145451:G:T | G32V | 0.988 |
| 20:145531:T:C | C59R | 0.987 |
| 20:145510:T:C | C52R | 0.986 |
| 20:145458:C:G | C34W | 0.985 |
| 20:145512:C:G | C52W | 0.985 |
| 20:145532:G:A | C59Y | 0.985 |
| 20:145511:G:A | C52Y | 0.984 |
dbSNP variants (sampled 300 via entrez): RS1000298173 (20:145189 T>A), RS1002247699 (20:140832 A>G), RS1002505884 (20:143205 G>A), RS1002988452 (20:142881 C>A,T), RS1003357974 (20:144370 C>T), RS1004424826 (20:142363 C>T), RS1004528375 (20:142391 G>A), RS1005125375 (20:142831 C>T), RS1005461813 (20:144353 G>A), RS1006204754 (20:143987 T>C), RS1007735663 (20:145173 C>G,T), RS1008326938 (20:143420 A>G), RS1008994534 (20:142257 A>G), RS1009215751 (20:141470 T>C), RS1009439721 (20:141858 C>A,T)
Disease associations
OMIM: gene MIM:620131 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation | 1 |
| Cyclosporine | increases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.